The value of melatonin for sleep disorders occuring post-head injury: A pilot RCT

St. James University, Сент-Джеймс, New York, United States
Brain Injury (Impact Factor: 1.81). 10/2004; 18(9):911-9. DOI: 10.1080/02699050410001671892
Source: PubMed


Whilst there is data to support the use of Melatonin in treating disorders of the sleep-wake cycle, so far there is little published evidence on the efficacy of Melatonin in treating the prevalent condition of post-TBI sleep disturbance.
The present work used a randomized double-blind controlled cross-over trial to compare Melatonin (5 mg) and Amitriptyline (25 mg) in a small sample of TBI patients presenting with chronic sleep disturbance.
No differences in sleep latency, duration, quality or daytime alertness were found for either drug compared to baseline using significance testing. However, effect sizes revealed some encouraging changes. Patients on Melatonin reported improved daytime alertness compared to baseline. On Amitriptyline, patients reported increased sleep duration compared to baseline.
The study provides preliminary evidence for the value of Melatonin and Amitriptyline in treating sleep disorder post-TBI. There were no adverse drug effects. Suggestions are made for ongoing investigation for the treatment of this prevalent condition.

1 Follower
26 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent studies show the possibility of using amorphous materials as current sensors. In this paper, the magnetoresistance effect existing in multilayer (Co<sub>50</sub>Ni<sub>25</sub>)<sub>10</sub> structures has been used to develop a current sensor susceptible to be fully integrated. Experimental results have been obtained to compare the properties of the anisotropic magnetoresistance effect (AMR) with commercial ones
    No preview · Conference Paper · Mar 1998
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the 1970s and early 1980s, neuroendocrinology was viewed by many neuroscientists as a "window to the brain" to an understanding of brain function." In psychiatry, many have viewed sleep physiology as a window in biological psychiatry. This is, in part, because sleep is one of the few easily quantifiable functions of interest to psychiatrists. Melatonin is a hormone with powerful effects on behavior particularly circadian and sleep behavior. In contrast with other hormones, the pathophysiology and pathology of abnormal melatonin secretion is poorly understood. In this article, we document the well-established phase-shifting and sleep-promoting effects of melatonin and discuss some implications for neuropsychiatrists when the neurophysiology of melatonin goes array. It is both striking and in some ways not surprising that the majority of patients with phase delay syndrome described in our research studies have been misdiagnosed as having depression. The reason for this is elucidated in this article and the information concerning this condition may be helpful to many who are relatively unfamiliar with this particular sleep disorder. We can anticipate that patients with specific neurological disorders may have changes in their melatonin secretion and future research, for example in patients with head injury and conditions such as retinitis pigmentosa may be the basis for reviews a few years hence.
    No preview · Article · Feb 2000 · Seminars in Clinical Neuropsychiatry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Normal circadian rhythms are synchronized to a regular 24 hr environmental light/dark (L/D) cycle. Both suprachiasmatic nucleus (SCN) and melatonin are essential for this adaptation. Desynchronization of circadian rhythms as occurs in chronobiological disorders result in severe disturbances of sleep. The Circadian rhythm sleep Disorders (CRSDs) include delayed sleep phase syndrome (DSPS), Non 24 hr sleep/wake rhythm disorder, jet lag and shift-work. Depression also shows circadian rhythm disturbances. Disturbances in the phase position of plasma melatonin levels have been documented in all these disorders. Whether this melatonin disruption is a cause or a consequence of the disorders is not known. Further research of a larger number of patients with CRSDs can help to determine the association. At present there appears to be a role of endogenous melatonin in the pathophysiology of these circadian rhythm sleep disorders. Exogenous melatonin is useful in treating the disturbed sleep-wake rhythms seen in DSPS, Non 24 hr sleep/wake rhythm, Shift-work sleep disorder, jet lag and in depression. The magnitude and direction of the shift of the sleep-wake rhythm depend upon the time of melatonin onset. In most of these conditions an abnormal phase position of melatonin rhythm has been documented
    No preview · Chapter · Dec 2004
Show more